Defining On-Treatment Remission in Plaque Psoriasis
Through a Delphi consensus process, on-treatment remission for plaque psoriasis was defined as patients maintaining a BSA involvement of 0% or IGA of 0 for at least 6 months while on treatment. This clear and standardized benchmark is applicable to both research and practice settings.
Authors
- Steven R. Feldman (ORCID: https://orcid.org/0000-0002-0090-6289)
- Ronald Prussick (ORCID: https://orcid.org/0000-0002-9375-2097)
- April Armstrong (ORCID: https://orcid.org/0000-0003-3729-9811)
- Charlotte Read
- Yasmin Gutierrez (ORCID: https://orcid.org/0000-0003-0263-1511)
- G. Michael Lewitt
- Stephanie T. Le (ORCID: https://orcid.org/0000-0001-5142-7010)
- Deepak Balak (ORCID: https://orcid.org/0000-0002-0755-3770)
- Cheryl F. Rosen (ORCID: https://orcid.org/0000-0002-5807-0445)
- Joel M. Gelfand (ORCID: https://orcid.org/0000-0003-3480-2661)
- Emanual Maverakis
- Tina Bhutani (ORCID: https://orcid.org/0000-0001-8187-1024)
- Gil Yosipovitch (ORCID: https://orcid.org/0000-0001-6303-1822)
- José U. Scher (ORCID: https://orcid.org/0000-0002-1072-6994)
- Lourdes M. Pérez-Chada (ORCID: https://orcid.org/0000-0001-7724-7309)
- Robert E. Kalb
- Steven Fakharzadeh
- Samuel Hwang (ORCID: https://orcid.org/0000-0001-7930-9964)
- Joseph Frank Merola (ORCID: https://orcid.org/0000-0001-6514-4353)
- Dafna D. Gladman (ORCID: https://orcid.org/0000-0002-9074-0592)
- George Han (ORCID: https://orcid.org/0000-0003-3302-5098)
- Paul S. Yamauchi
- Evan Siegel
- Alyssa Roberts (ORCID: https://orcid.org/0000-0001-8905-4432)
- Leon Kircik (ORCID: https://orcid.org/0000-0002-0831-2151)
- Richard G. Langley (ORCID: https://orcid.org/0000-0003-4730-2164)
- Jason E. Hawkes (ORCID: https://orcid.org/0000-0001-5870-181X)
- George Gondo (ORCID: https://orcid.org/0000-0002-6468-0397)
- Wilson Liao (ORCID: https://orcid.org/0000-0001-7883-6439)
- Guy S. Eakin (ORCID: https://orcid.org/0000-0003-2387-0693)
- Nicole Johnsen (ORCID: https://orcid.org/0009-0006-1072-301X)
- Lawrence J. Green (ORCID: https://orcid.org/0000-0002-1295-9249)
- Soumya M. Reddy (ORCID: https://orcid.org/0000-0002-8689-0387)
- Kristina Callis Duffin
- Jeffrey M Weinberg
- Brad Glick
- Mark Lebwohl
- Elizabeth B. Wallace
- Andrew Blauvelt
Institutions
- University of California, Riverside (US)
- University of Southern California (US)
- University of Hawaiʻi at Mānoa (US)
- Brigham and Women's Hospital (US)
- Dalhousie University (CA)
- University Health Network (CA)
- Johnson & Johnson (United States) (US)
- Harvard University (US)
- University of Miami (US)
- University of California, Los Angeles (US)
- University of California, San Francisco (US)
- Georgetown University (US)
- University of Toronto (CA)
- Rosalind Franklin University of Medicine and Science (US)
- George Washington University (US)
- University of Utah (US)
- Toronto Western Hospital (CA)
- Leiden University Medical Center (NL)
- Palm Springs General Hospital (US)
- NYU Langone Health (US)
- National Psoriasis Foundation (US)
- ASIS Foundation (US)
- Southwestern Medical Center (US)
- Maryland Department of Natural Resources (US)
- Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US)
- Arthritis and Rheumatism Associates (US)
- Denova Research (US)
- Illinois Public Health Institute (US)
- Oregon Medical Research Center (US)
- DermResearch (United States) (US)
- Synergy Health (US)
- Janssen (United States) (US)
- Krembil Research Institute
- Indiana University School of Medicine
- Wake Forest University (US)
- Indiana University – Purdue University Indianapolis (US)
- New York University (US)
- University at Buffalo, State University of New York (US)
- University of Pennsylvania (US)
- University of California, Davis (US)
- The University of Texas Southwestern Medical Center (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1001/jamadermatol.2025.1625
- Citations
- 4
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 3.19